Dr. Maria Zimmermann‑Kogadeeva is a leading computational biologist and group leader in the Genome Biology Unit at EMBL in Heidelberg. After earning her PhD in 2016 from ETH Zürich’s Institute of Molecular Systems Biology, she completed postdoctoral studies at Yale—where she co-led a project revealing that gut microbes metabolize hundreds of drugs —and at EMBL, supported by Swiss National Science Foundation and AXA Research Fund fellowships.
Her lab pioneers the integration of multi-omics data (including metabolomics, transcriptomics, proteomics) with computational modeling to decode how individual microbes adapt metabolically within communities and interact with their environment and host. This interdisciplinary approach has uncovered key insights: notably, bacterial contributions to human drug metabolism and regulatory mechanisms that enhance microbial fitness in the gut.
In recognition of her trailblazing work bridging data science, microbial ecology, and host-microbe interactions, Dr. Zimmermann‑Kogadeeva received the Bayer Foundation’s Early Excellence in Science Award in 2021.
Today, Dr. Zimmermann‑Kogadeeva leads a vibrant research team at EMBL Heidelberg, pushing boundaries in systems microbiology to reveal metabolic mechanisms that underpin microbial community behavior and host interactions.
Contact
Dr. Maria Zimmermann-Kogadeeva
Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany
Email: maria.zimmermann@embl.de